Related Experiment Video
Updated: Jan 30, 2026

Isolation of Primary Human Colon Tumor Cells from Surgical Tissues and Culturing Them Directly on Soft Elastic Substrates for Traction Cytometry
Published on: June 4, 2015
Antiproliferative Effect of Amaranth Proteins and Peptides on HT-29 Human Colon Tumor Cell Line
Ana Clara Sabbione1, Fredrick Onyango Ogutu2, Adriana Scilingo1
1Centro de Investigación y Desarrollo en Criotecnología de Alimentos (CIDCA), Facultad de Ciencias Exactas-UNLP, CONICET, CIC, Calle 47 y 116 - 1900, La Plata, Argentina.
Abstract:
Antiproliferative effect of Amaranthus mantegazzianus proteins and peptides released after simulated gastrointestinal digestion (DH% 37.8 ± 3.8) was investigated on human colon cancer cell line HT-29. Inhibition of proliferation of HT-29 cells was exhibited after a 24 h treatment with different concentrations of amaranth protein isolate (API) and the peptides released after digestion (DGS), presenting IC50 values of 1.35 ± 0.12 and 0.30 ± 0.07 mg soluble protein/mL, respectively. Lactate dehydrogenase assay indicated that both samples caused the loss of membrane integrity and cell lysis over HT-29 cells, and DAPI fluorescence microscopies evidenced typical apoptotic features. Moreover, Annexin V-FITC flow cytometry showed a significant increase of early apoptotic and late apoptotic/necrotic HT-29 cells compared to untreated ones, and caspase-3 assay confirmed the apoptosis induction with a 43.0 ± 10.3 and 65.8 ± 12.7% increase of caspase-3 activity produced by a 2 mg/mL treatment of API and DGS, respectively. In conclusion, amaranth peptides successfully released after simulated gastrointestinal digestion would exert a potential antiproliferative activity over HT-29 tumor cells. This effect was linked to the induction of cell necrosis and apoptosis, supporting the idea of using amaranth proteins as a potential food alternative ingredient for functional foods.
Insights
Amaranth peptides, released after digestion, show significant antiproliferative effects on human colon cancer cells (HT-29). These peptides induce apoptosis and necrosis, suggesting potential use in functional foods.
Area of Science:
- Food Science
- Biochemistry
- Cancer Research
Background:
- Amaranth protein isolate (API) and its derived peptides (DGS) are explored for health benefits.
- Colon cancer remains a significant health concern, necessitating novel therapeutic strategies.
Purpose of the Study:
- To investigate the antiproliferative effects of amaranth protein isolate and its digested peptides on the human colon cancer cell line HT-29.
- To elucidate the mechanisms underlying the antiproliferative activity, including apoptosis and necrosis induction.
Main Methods:
- In vitro study using HT-29 cells treated with API and DGS.
- Assays included proliferation inhibition, lactate dehydrogenase release, DAPI staining, Annexin V-FITC flow cytometry, and caspase-3 activity.
- Simulated gastrointestinal digestion was performed to obtain DGS.
Main Results:
- Both API and DGS exhibited antiproliferative effects on HT-29 cells, with DGS showing higher potency (IC50: 0.30 mg/mL vs 1.35 mg/mL for API).
- Lactate dehydrogenase assay and DAPI staining indicated cell membrane damage, lysis, and apoptosis.
- Annexin V-FITC and caspase-3 assays confirmed significant induction of early and late apoptosis/necrosis.
Conclusions:
- Amaranth peptides, particularly those released after simulated gastrointestinal digestion, possess significant antiproliferative activity against HT-29 colon cancer cells.
- The observed effects are mediated through the induction of apoptosis and necrosis.
- Amaranth proteins and their peptides represent a promising ingredient for developing functional foods with potential anti-cancer properties.
More Related Videos
Related Concept Videos
Peptide Bonds
The Colonization of Land
Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme...
Role of Proteins in the Human Body
Protein Digestion
What are Proteins?

